The high incidence of amyotrophic lateral sclerosis (ALS) and parkinsonism-dementia complex (PDC) has been previously known in the Kii Peninsula of Japan and in Guam. Recently, the accumulation of various proteins, such as tau, trans-activation response DNA binding protein 43 kDa (TDP-43), and alpha-synuclein (αSyn), was reported in the brains of patients with ALS/PDC in Guam. To confirm whether similar findings are present in Kii ALS/PDC, we neuropathologically examined the brains and spinal cords of 18 patients with ALS/PDC (clinical diagnoses: eight ALS and 10 PDC) in Hohara Village, which is the eastern focus of Kii ALS. The average age at death was 71.6 years, and 16 patients (88.9%) had a family history of ALS/PDC. Autopsy specimens were immunohistochemically examined with antibodies against four major proteins. Neurofibrillary tangles, including ghost tangles, and tau-positive astrocytes were distributed widely in all of the brains examined, and TDP-43-positive neuronal cytoplasmic inclusions were observed mainly in the limbic system. Synuclein pathology was present in 14 patients (77.8%). These patients were classified into three pathological subtypes according to the most prominent proteinopathy: the tauopathy-dominant type, the TDP-43 proteinopathy-dominant type, and the synucleinopathy-dominant type. Five patients with severe tau deposition showed clinical features of atypical parkinsonism and dementia with or without motor neuron disease. Eight patients were predominated by phosphorylated TDP-43 inclusions and clinically showed ALS, and five patients were predominated by synuclein pathology and clinically showed signs of PDC. Based on the common characteristic tau pathology, three subtypes seemed to be pathologically continuous on a spectrum of a single disease. Thus, we conclude that ALS/PDC in the Hohara focus of the Kii Peninsula is a single disease characterized neuropathologically by a multiple proteinopathy, even though the clinical manifestations of the three subtypes differed from each other. It remains unclear whether the coexistence of the three proteinopathies was incidental or pathogenetically related.
INTRODUCTION
In addition to the pathological findings of sporadic amyotrophic lateral sclerosis (ALS), various degrees of neurofibrillary tangles (NFTs) were previously reported in the brains of Kii ALS. 1 Kii parkinsonism-dementia complex (PDC) was reported to be neuropathologically characterized macroscopically by frontotemporal atrophy and microscopically by the appearance of abundant NFTs. 2 On electron microscopy, the NFTs of Kii ALS/PDC comprised of paired helical filaments similar to those of Alzheimer's disease (AD) and Guamanian ALS/PDC. 2, 3 By immunoblotting with tau isoforms, the three major abnormal tau bands of 60, 64 and 68 kDa were detected, which indicated that the NFTs consisted of both 3-repeat tau and 4-repeat tau. These findings were similar to those in AD and Guamanian PDC. 4, 5 The presence of NFTs without senile plaques was thought to be unique to Guamanian ALS/PDC. NFTs were seen almost exclusively in Chamorros and reported to be frequently recognized in the brains of Chamorros without neurodegenerative diseases. 6 Abundant NFTs were shown
Correspondence: Mari Yoshida, MD, PhD, Department of Neuropathology, Institute for Medical Science of Aging, Aichi Medical University, 1-1 Yazakokarimata, Nagakute, Aichi 480-1195, Japan. Email: myoshida@ aichi-med-u.ac.jp throughout the brains of Guamanian patients with PDC, whereas in the brains of Guamanian patients with ALS, the amount of NFTs was reported to be the same as that in the brains of healthy Chamorros. On the basis of these findings, Anderson et al. and Oyanagi et al. proposed a hypothesis that the appearance of a considerable number of NFTs was not a pathologically specific finding of Guamanian ALS but instead represented background changes of the brains of both healthy and diseased Chamorros. 6, 7 Oyanagi et al. furthered this hypothesis and concluded that ALS in Guam is similar to the classical ALS-associated NFT pathology that is common in Chamorros. 6, 7 In our previous studies of the brains of Kii ALS/PDC cases from Hohara, 8, 9 which is the eastern focus of Kii ALS, the number of NFTs in the brains varied from minimal to abundant, whereas, in the brains of non-ALS/PDC patients of this focus, the number and distribution of NFTs were almost the same as those of Japanese controls from other areas.
Recently, the accumulation of several proteins in addition to tau was reported in brains of Guamanian ALS/PDC. [10] [11] [12] In this study, we investigated the pathological features of Kii ALS/PDC brains in the Hohara focus from the viewpoint of a multiple proteinopathy.
MATERIALS AND METHODS

Subjects
We examined material from 18 autopsied patients who fulfilled clinical forms for diagnostic criteria of Kii ALS/PDC from the Hohara focus. 13 All of them showed one or more of motor neuron symptoms, parkinsonism and dementia (Table 1) . Six patients were male, and 12 were female. The average age at disease onset was 62.8 years (ranging 51-76 years), the average age at death was 71.6 years (ranging 60-85 years), and the average duration of the disease was 8.7 years (ranging 1-15 years). The present study included 16 patients with positive family histories of ALS/PDC (10 different families as shown in Table 1 ), and two patients with unconfirmed family histories. Eight patients were classified as the clinical ALS subtype and 10 patients as the PDC subtype. Both ALS and PDC subtypes occurred in a single family in one of the 10 families. Clinical features of all patients were retrospectively reviewed from their medical records.
Methods
The brains were fixed in 20% buffered formalin and cut into coronal sections. Blocks were embedded in paraffin and cut into 4.5 or 9 μm-thick sections. For routine histological examination, all sections were stained with HE and KB. To assess the neuronal and glial inclusions, we selected several sections and stained them with the modified Gallyas-Braak method (GB) and several immunohistochemical stains. The following primary antibodies were used: phosphorylated tau (AT-8, monoclonal, Innogenetics, Zwijndrecht, Belgium, 1:5000), beta/A4 amyloid (Aβ) (6F/3D, monoclonal, Dako, Glostrup, Denmark, 1:100), phosphorylated trans-activation response DNA binding protein 43 kDa (TDP-43) (pS409/410, polyclonal, Cosmobio, Tokyo, Japan 1:4000), alpha-synuclein (αSyn) (polyclonal, Sigma-Aldrich, St. Louis, MO, USA, 1:10 000), phosphorylated αSyn (pSyn#64, monoclonal, Wako, Osaka, Japan, 1:10 000), CD68 (monoclonal, Dako, 1:1000), phosphorylated neurofilament (2F11, monoclonal, Dako, 1:400), 4-repeat tau (4R-tau, polyclonal, Cosmobio, 1:1000), 3-repeat tau (RD3, monoclonal, Upstate, Lake Placid, NY, USA, 1:4000), and p62 (polyclonal, Progen Biotechnik, Heidelberg, Germany, 1:4000). Immunostaining with anti-phosphorylated TDP-43, αSyn and phosphorylated αSyn was conducted after pretreatment with formic acid and microwaving in citrate buffer. Immunostaining with the monoclonal anti-Aβ antibody was carried out after pretreatment with formic acid. The sections were treated with 3% H 2 O 2 for 10 min to block the internal peroxidase. Then, the sections were immunostained overnight with antibodies. As a secondary detection system, the Envision plus kit (Dako) was used with 3 0 3-diaminobenzidine tetrahydrochloride (DAB D5637, Sigma-Aldrich) as the chromogen. All of the sections were counterstained lightly with hematoxylin.
Neuropathological assessment
Gliosis and neuronal loss were assessed by HE and KB. Lewy body pathology was assessed by the modified guidelines of previous consensus guidelines. 14 
Characteristics common to all cases
Macroscopically, the hippocampus showed moderate to severe atrophy in all 18 patients (Fig. 1A) . Microscopically, NFTs were observed on GB and immunohistochemical staining with AT8. NFTs were positive on both 3-repeat tau and 4-repeat tau immunohistochemistry. The NFTs of these patients looked similar to those from patients with AD individually, but differed in terms of their distribution and association with neuropil threads; the NFTs of ALS/PDC were predominantly found in the superficial layers of the cerebral cortex while those of AD were more predominantly found in the deep layers than in the superficial layers (Fig. 1B) . NFTs tended to appear discontinuously and non-systematically; for instance, NFTs were observed in the premotor gyrus, dentate nucleus, pontine nucleus, and anterior horn of the spinal cord, even though their densities were low. Therefore, it was difficult to stage the NFTs using the Braak and Braak neurofibrillary stage in these ALS/PDC cases. 17 Neuropil threads were scarce in Kii ALS/PDC compared with AD brains. By contrast, ghost tangles were abundant in all cases, although the NFT densities were not high (Fig. 1C) . Ghost tangles were present mainly in the amygdala, CA1, and the locus coeruleus and were also diffusely observed in the cerebral cortex. For glial inclusions, Gallyas-positive and tau-positive astrocytes were observed in all cases (Fig. 1D ). These astrocytes were found predominantly in subpial and perivascular areas, and were also focally present in the white matter. Coiled bodies were found at the basal ganglia and the cortex, but typical tufted-astrocytes were not observed.
Tauopathy-dominant type
In five of 18 patients, tau pathology was the most severe of all the proteinopathies (Case numbers 9-13 in Table 1 and Fig. 2 ). Macroscopically, brain atrophy was most severe in this type, especially in the brainstem, frontal cortex and temporal cortex. The average brain weight of this type was 996.4 g. All five patients showed discoloration of the substantia nigra and locus coeruleus, and anterior roots of the spinal cord were atrophied in one patient who had clinically shown motor neuron symptoms. Microscopically, numerous NFTs were observed in the limbic area ( Fig. 2A) . Ghost tangles were severe throughout the brain, especially the amygdala, hippocampus, parahippocampus, locus coeruleus and Meynert nucleus. In ghost tangles, tau immunoactivity and argyllophilia are reduced; therefore, the density of NFTs appeared lower on GB and immunohistochemical staining with AT8 than actually existed in the tauopathy-dominant type. These ghost tangles were so faintly stained with eosin or hematoxylin that they appeared pale compared with the other structures and were easily recognized. All five patients had many taupositive astrocytes and coiled bodies. Two of the five patients showed astrocytic plaque-like structures and threads at the basal ganglia, at the frontal cortex, including the premotor cortex, and at the temporal cortex, with ballooned neurons (Fig. 3A,B) . In these areas, 4-repeat tau-positive glial inclusions and threads were more prominent than 3-repeat taupositive inclusions (Fig. 3C,D) . Although these findings were similar to those seen with typical corticobasal degeneration (CBD), the astrocytic plaque-like structures in these patients were generally smaller than those of typical CBD, and the threads tended to be thin and poor.
All five patients had NCI and GCI in immunostaining with phosphorylated TDP-43 antibodies. TDP-43-positive dots were also observed. The distribution of phosphorylated TDP-43-positive inclusions were predominantly seen in the limbic system, including the dentate gyrus (Fig. 2B) , and four of five patients showed skein-like inclusions with a loss of motor neurons. All five patients showed synuclein pathology (Fig. 2C) : two with the limbic type of Lewy body pathology, and three had limbic dominant synuclein-positive inclusions without Lewy bodies. Synuclein pathology at the peripheral nervous system, including sympathetic ganglion, Meissner's plexus of gastrointestinal tract and cardiac sympathetic fibers, was examined in four patients, and one patient showed Lewy bodies and neurites. Three of the five patients showed amyloid pathology: two patients were at Braak plaque stage A, and one was at stage C.
The patients of the tauopathy-dominant type showed a clinically atypical PDC subtype; for instance, one patient associated with ALS, two patients showed rapidly progressive parkinsonism with upper motor signs, and one showed marked dementia with behavior abnormality.
TDP-43 proteinopathy-dominant type
In eight of 18 cases, TDP-43 pathology was the most severe of all the proteinopathies (Case numbers 1-8 in Table 1 and Fig. 2) . Macroscopically, the anterior roots of the spinal cord were atrophied. The average brain weight of the patients of this type was 1184.3 g. The frontal lobe, including the premotor cortex or temporal cortex, showed mild to moderate atrophy. Approximately 80% of the eight patients showed discoloration of the substantia nigra and locus coeruleus.
Microscopically, the motor neurons were moderately to severely decreased, although gliosis was relatively mild. All eight patients showed Bunina bodies, with a relatively mild loss of Betz cells (Fig. 4A) . Following immunostaining with phosphorylated TDP-43 antibodies, all eight patients showed skein-like inclusions, NCIs, GCIs and dots (Fig. 4B,C) . NCIs and GCIs were mainly distributed in the motor neurons and limbic systems, including the dentate gyrus, and spread to basal ganglia, tegmentum of the brainstem, and many other regions (Brettschneider's ALS stage IV, Fig. 2B ). Several NCIs were irregular in shape, and GCIs were structurally similar to those of sporadic ALS. GCIs were found in the white matter also, although far less than in the gray matter. Neuronal nuclear inclusions (NNI) and dystrophic neurites were rare (Fig. 4D) .
Five of the above eight patients showed synuclein pathology ( Fig. 2C ): three patients with brainstem-type Lewy body pathology, and two with limbic-type Lewy body pathology. Two of these five patients were submitted for synuclein pathology at peripheral nervous system. All two patients showed Lewy bodies and neurites at the peripheral nervous system. Four of the above eight patients showed amyloid pathology, two patients were at Braak plaque stage A, and two patients were at stage B.
All eight patients in the TDP-43 proteinopathydominant type showed the clinical ALS subtype. Cardiac meta-iodobenzyl guanidine I 123 (MIBG) scintigraphy was examined in four of eight patients; one patient (Case 5) with a lack of uptake showed clinical signs of parkinsonism.
Synucleinopathy-dominant type
In five of 18 patients, synuclein pathology was the most severe of all of the proteinopathies (Case numbers 14-18 in Table 1 and Fig. 2) . Macroscopically, the average brain weight of this type was 1206.3 g, and all five patients showed discoloration of the substantia nigra and locus coeruleus. Mild to moderate atrophy of the frontal or temporal lobe was also observed.
Microscopically, all five of these patients experienced cell loss and Lewy bodies on HE at the dorsal vagal nucleus, locus coeruleus and substantia nigra. In immunostaining with the phosphorylated αSyn antibody, all five patients showed Lewy bodies, Lewy neurites and Lewy dots (Fig. 5B) . Two patients showed neocortical-type Lewy body pathology, and three patients showed limbictype Lewy body pathology (Fig. 5A) . Synuclein pathology at the peripheral nervous system was examined in four patients, all of whom showed Lewy body pathology at the peripheral nervous system (Fig. 5C,D) . The distribution of Lewy bodies and neurites were basically similar to that of ordinary Lewy body disease, but Lewy neurites and dots were seen to be dominant in the superficial layers of the cortex. Synuclein pathology was not found so much in the white matter.
All five patients showed NCI and GCI with immunostaining with phosphorylated TDP-43 antibody, although there were no neuronal inclusions in the motor neuron system (Fig. 2B) . All five patients also had senile plaques or cerebral amyloid angiopathy, three patients were at Braak plaque stage A, and one each was at stage B and C.
All five patients in this type clinically showed the PDC subtype. Cardiac MIBG scintigraphy was examined in four patients, and all four patients showed a lack of uptake.
DISCUSSION
The present study showed characteristic pathological and immunohistochemical features common to all 18 patients with ALS/PDC as follows: first, NFTs and ghost tangles were distributed widely throughout each brain; second, taupositive astrocytes were observed mainly in the subpial and perivascular regions; and third, TDP-43 positive NCIs were observed mainly in the limbic system. Previous studies reported that the NFTs of Kii ALS/PDC were similar to those of AD on western blotting and electron microscopy. 2, 5 However, NFTs in Kii ALS/PDC were more widely but discontinuously distributed than those in AD, from primary motor and sensory cortices down to the spinal gray matter. Ghost tangles and tau-positive astrocytes in ALS/PDC were more prominent than in AD, whereas neuropil threads and senile plaques were less prominent in most patients. In terms of tau pathology, the present 18 patients shared the same tau pathology and thus, are characterized by a single disease. Similar neuropathological findings and western blotting patterns were reported in Guamanian ALS/PDC. 4, 10 In Guamanian PDC, characteristic tau-positive glia called granular hazy astrocytes, were reported. 19 The present patients showed Gallyas-and tau-positive astrocytes of various structures and coiled bodies. These astrocytes included thorn-shaped astrocytes, granular or fuzzy astrocytes, and granular hazy astrocytes. Two of the 18 patients showed astrocytic plaque-like structures and threads reminiscent of CBD pathology, although plaque-like structures were smaller in the extension and the threads and thinner in fibril size than those of typical CBD pathology. The present study revealed that in addition to the core tauopathy and TDP proteinopathy, synuclein pathology and amyloid pathology were present more frequently than previously reported 2 (Fig. 2) . Ten of the 18 patients showed all four proteinopathies, six patients three proteinopathies, and the remaining two patients tauopathy and TDP proteinopathy only. Miklossy et al. reported pathological accumulations of tau, Aβ, αSyn and TDP-43 in Guamanian ALS/PDC and that the accumulations of αSyn increased as tau deposits became severe. 12 From these findings, they concluded that severe tau pathology dominated the pathological picture, but Aβ, αSyn and TDP-43 pathology were also implicated in the pathogenesis of the disease. The frequencies of tau-, Aβ-, αSyn-and TDP-43-positive cases were almost similar between ALS/PDC patients of Hohara and of Guam. However, in Hohara patients, tau did not always dominate the pathological picture and αSyn accumulation was not always associated with the tau accumulation. These findings are not consistent with the hypothesis that tau induces the accumulation of other proteins but imply that either of them could be accumulated primarily and induce accumulation of the others. Based on findings of the present study, 18 ALS/PDC patients of the Hohara focus were classified into three pathological subtypes according to the most predominantly manifested proteinopathy: tauopathy-dominant, TDP-43 proteinopathy-dominant and synucleinopathy-dominant types. In addition to the characteristic tau pathology, patients of the TDP-43 proteinopathy-dominant type showed pathological features identical to those of sporadic ALS patients, including Bunina bodies and skein-like inclusions. However, on TDP-43 immunohistochemistry, NCIs were more irregular in shape, and there were more dots in the superficial layers of the cortex in ALS/PDC than in sporadic ALS. In addition to the characteristic tau pathology, patients of the synuclein proteinopathy-dominant type showed synuclein pathology in not only the central nervous system, but also the peripheral autonomic nervous system. On synuclein immunohistochemistry, Lewy bodies were more irregular in shape, and there were more Lewy dots in the superficial layers of the cortex in ALS/PDC than in Lewy body disease. Each proteinopathy was most predominant in the limbic system in all patients (Fig. 2) . All patients of the tauopathy-dominant type and 50% of patients of the TDP-43 proteinopathy-dominant type had synuclein pathology, whereas 80% of patients of the tauopathy-dominant type had classical ALS pathology. From the above findings, these three subtypes appear to be continuous pathologically on a spectrum of a single disease.
In Hohara ALS/PDC patients, tau-positive astrocytes were preferentially seen in the perivascular regions and subpial and superficial layers of the cortex and focally in the white matter. The granular or fuzzy astrocytes seen in the present cases were similar to those reported in agingrelated tau astrogliopathy. 20 The appearance of many ghost tangles and granular or fuzzy astrocytes has been recognized to be characteristic of very old brains. Shiraki indicated that the neuropathological features of ALS of Kii and Guam were reminiscent of those of aged brains, and he implied that, pathogenetically, they might be a kind of progeria or accelerated aging of the CNS. 21 
CONCLUSION
Thus, we conclude that ALS/PDC of the Hohara focus of the Kii Peninsula is a single disease characterized by multiple proteinopathies, even though the clinical manifestations of the three subtypes differ from each other.
